A Sponsor’s Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan
Pharmaceutical Medicine · 2024
DOI: 10.1007/s40290-024-00521-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Medicine, 2024. Verfasst von Kevin D Wolter und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer, Groton, CT, USA. Hauptthemen laut MEDLINE: Product Surveillance, Postmarketing, Drug Approval. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pfizer, Groton, CT, USA.
- Pfizer, Tokyo, Japan.
- Pfizer R&D UK Limited, Dorking Road, Tadworth, Surrey, KT20 7NS, UK. Rod.Junor@Pfizer.com.
ORCID-Profile: Rod Junor
Förderung
- Pfizer
Zitieren
APA
Wolter, K. D., Kamatani, A., Suzuki, Y., Imaeda, T., Dagher, R., Safferman, A., & Junor, R. (2024). A Sponsor’s Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan. Pharmaceutical Medicine. https://doi.org/10.1007/s40290-024-00521-2
Vancouver
Wolter KD, Kamatani A, Suzuki Y, Imaeda T, Dagher R, Safferman A, et al. A Sponsor’s Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan. Pharmaceutical Medicine. 2024. doi:10.1007/s40290-024-00521-2
BibTeX
@article{Wolter2024,
author = {Wolter, Kevin D and Kamatani, Asayuki and Suzuki, Yumiko and Imaeda, Takayuki and Dagher, Ramzi and Safferman, Allan and Junor, Rod},
title = {A Sponsor’s Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan},
journal = {Pharmaceutical Medicine},
year = {2024},
doi = {10.1007/s40290-024-00521-2}
}
EUVIMED